Abstract
There is now a considerable amount of evidence suggesting that the biogenic amines are involved in the etiology of the affective disorders. This evidence consists of a growing number of investigations of the biogenic amines in patients suffering from depression and mania, and also of observations of the effect of manipulating brain amines on mood in patients and in normal subjects. This paper will examine some of the direct evidence for a disturbance in biogenic amines in patients suffering from affective disorders, to examine the etiological implications of these findings, and to consider what the implications of these findings are for treatment. I shall be dealing with the indoleamines—serotonin (5-hydroxytryptamine) and tryptamine—whose biosynthesis and metabolism are illustrated in Figure 1. I do this not because I naively think that only serotonin is important in these conditions, but because most of my own research interests have been centered in this area; in a later paper, Dr. Schildkraut will describe catecholamine metabolism in affective disorders. Moreover, I should like to stress my view that the clinical pathology of the affective disorders is probably very complex, involving not only the biogenic amines but probably other abnormalities as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ashcroft, G. W.; Crawford, T. B. B.; Eccleston, D.; Sharman, D. F.; MacDougall, E. J.; Stanton, J. B.; and Binns, J. F. 1966. 5-Hydroxy-indole compounds in the cerebrospinal fluid of patients with psychiatric or neurological disease. Lancet 2:1049.
Bourne, H. R.; Bunney, W. E.; Colburn, R. W.; Davis, J. N.; Davis, J. M.; Shaw, D. M.; and Coppen, A. J. 1968. Noradrenaline, 5-hy-droxytryptamine and 5-hydroxyindoleacetic acid in the hindbrains of suicidal patients. Lancet 2:805.
Bowers, M. B.; Heninger, G. R.; and Gerbode, F. 1969. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients. Int. J. Neuropharmacol. 8:255.
Bunney, W. E., and Davis, J. M. 1965. Norepinephrine in depressive reactions. Arch. Gen. Psychiat. 13:483.
Coppen, A. 1967. Mineral metabolism in affective disorders. Brit. J. Psychiat. 111:1133.
Coppen, A.; Prange, A. J.; Whybrow, P. C.; Noguera, R.; and Paez, J. M. 1959. Methysergide in mania. Lancet 2:338.
Dencker, S. J.; Malm, V.; Roos, B.-E.; and Werdinius, B. 1966. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem. 13:1545.
Dewhurst, W. G. 1968. Methysergide in mania. Nature 219:506.
Glassman, A. H., and Platman, S. R. 1970. Potentiation of a monoamine oxidase inhibitor by tryptophan. J. Psychiat. Res. 7:63.
Goodwin, F. K.; Brodie, H. K. H.; Murphy, D. L.; and Bunney, W. E. 1970. Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients. Lancet 1:908.
Joyce, D. 1962. Changes in the 5-hydroxytryptamine content of rat, rabbit and human brain after death. Brit. J. Pharmacol. 18:370.
Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; and Pohlmeier, H. 1970. L-dopa plus decarboxylase inhibitor in depression. Lancet 2:660.
Pare, C. M. B. 1963. Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet 2:527.
Pare, C. M. B.; Young, D. P. H.; Price, K.; and Stacey, R. S. 1969. 5-Hydroxytryptamine, noradrenaline and dopamine in brainstem, hy-pothalamus and caudate nucleus of controls and patients committing suicide by coal gas poisoning, Lancet 2:133.
Shaw, D. M.; Camps, F. E.; and Eccleston, E. 1967. 5-Hydroxytryptamine in the hindbrains of depressive suicides. Brit. J. Psychiat. 113:1407.
Sjöström, R., and Roos, B.-E. 1970. Measurement of 5-HIAA and HVA in CSF in manic-depressive patients after probenecid application. Seventh Congress, Collegium Internationale Neuro-Psychopharmaco-logicum, Prague, Czechoslovakia.
van Praag, H. M.; Korf, J.; and Puite, J. 1970. 5-Hydroxyindole-acetic acid levels in the cerebrospinal fluid of depressed patients treated with probenecid. Nature 225:1259.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Coppen, A. (1971). Biogenic Amines and Affective Disorders. In: Ho, B.T., McIsaac, W.M. (eds) Brain Chemistry and Mental Disease. Advances in Behavioral Biology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3057-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3057-8_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3059-2
Online ISBN: 978-1-4684-3057-8
eBook Packages: Springer Book Archive